Table 1.

Baseline characteristics of the plaque enhancement groups.

	Total (n = 69)	No/Mild enhancement group (n = 40)	Obvious enhancement group (n = 29)	p value
Demographic data
Age	58.3 (11.6)	58.1 (12.4)	58.6 (10.7)	0.865
Male	51 (73.9)	29 (72.5)	22 (75.9)	0.754
History
Smoking	36 (52.2)	20 (50.0)	16 (55.2)	0.671
Drinking	23 (33.3)	15 (37.5)	8 (27.6)	0.389
Hypertension	48 (69.6)	29 (72.5)	19 (65.5)	0.534
Diabetes mellitus	26 (37.7)	16 (40.0)	10 (34.5)	0.641
Dyslipidemia	26 (37.7)	13 (32.5)	13 (44.8)	0.297
Coronary artery disease	11 (15.9)	6 (15.0)	5 (17.2)	1.000
Interval from onset to admission	5.03 (3.00–16.12)	9.95 (3.00–19.83)	4.01 (3.00–7.91)	0.093
Degree of stenosis	85 (70–90)	80 (64–90)	90 (71–100)	0.051
Stenosis site				0.935
Anterior circulation	52 (75.4)	30 (75.0)	22 (75.9)
Posterior circulation	17 (24.6)	10 (25.0)	7 (24.1)